Trial Profile
A retrospective study to evaluate the effect of Brentuximab vedotin followed by allogeneic stem cell transplantation in subjects with relapsed or refractory Hodgkin's lymphoma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 27 Nov 2015 New trial record